发布求助
文献互助 智能选刊 最新文献

La Presse Médicale Formation最新文献

筛选
英文 中文
Le dépistage de l’hypertension artérielle : enjeux, méthodes et innovations 高血压筛查：挑战、方法和创新
La Presse Médicale Formation Pub Date : 2025-08-01 DOI: 10.1016/j.lpmfor.2025.100688
Jean-Jacques Mourad
{"title":"Le dépistage de l’hypertension artérielle : enjeux, méthodes et innovations","authors":"Jean-Jacques Mourad","doi":"10.1016/j.lpmfor.2025.100688","DOIUrl":"10.1016/j.lpmfor.2025.100688","url":null,"abstract":"<div><div>Le dépistage de l’hypertension artérielle (HTA) est largement perfectible et bride la protection cardiovasculaire conférée par la prise en charge effective de la pathologie une fois diagnostiquée. La connaissance par un individu de son niveau tensionnel doit être aussi évidente que celle de son poids. Afin de diminuer durablement le pourcentage d’hypertendus qui s’ignorent, des actions concertées et durables doivent être mises en place, impliquant les professionnels de santé et les autorités sanitaires.</div></div><div><div>There is considerable room for improvement in screening for high blood pressure, blunting the cardiovascular protection afforded by effective management once it has been diagnosed. An individual's knowledge of their blood pressure level should be as obvious as of their weight. In order to achieve a lasting reduction in the percentage of people with hypertension who are unaware of their condition, concerted and sustained action must be taken, involving healthcare professionals and the health authorities.</div></div>","PeriodicalId":100859,"journal":{"name":"La Presse Médicale Formation","volume":"6 4","pages":"Article 100688"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144912856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
La réadaptation cardiovasculaire, un arsenal thérapeutique idéal pour la prévention secondaire des femmes ! 心血管康复是女性二级预防的理想治疗武器！
La Presse Médicale Formation Pub Date : 2025-08-01 DOI: 10.1016/j.lpmfor.2025.100694
Laura Serrano
{"title":"La réadaptation cardiovasculaire, un arsenal thérapeutique idéal pour la prévention secondaire des femmes !","authors":"Laura Serrano","doi":"10.1016/j.lpmfor.2025.100694","DOIUrl":"10.1016/j.lpmfor.2025.100694","url":null,"abstract":"","PeriodicalId":100859,"journal":{"name":"La Presse Médicale Formation","volume":"6 4","pages":"Article 100694"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144912517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
La dénervation rénale : où en est-on en 2025 ? 肾功能衰竭：2025年的情况如何？
La Presse Médicale Formation Pub Date : 2025-08-01 DOI: 10.1016/j.lpmfor.2025.100693
Romain Boulestreau , Atul Pathak
{"title":"La dénervation rénale : où en est-on en 2025 ?","authors":"Romain Boulestreau ,&nbsp;Atul Pathak","doi":"10.1016/j.lpmfor.2025.100693","DOIUrl":"10.1016/j.lpmfor.2025.100693","url":null,"abstract":"<div><div>La dénervation rénale est une stratégie innovante validée pour réduire efficacement la pression artérielle chez les patients hypertendus avec HTA résistante d’une part, légère d’autre part.</div><div>Son efficacité moyenne équivaut à celle d’un médicament antihypertenseur à pleine dose, mais la réponse reste hétérogène selon les patients.</div><div>L’identification de marqueurs prédictifs de réponse à la dénervation rénale constitue un enjeu majeur pour optimiser la sélection des candidats.</div><div>En l’absence de tels biomarqueurs, le respect strict du parcours de soin proposé par le consensus français reste la meilleure garantie d’une indication appropriée.</div><div>En France, la dénervation rénale est prise en charge pour les patients ayant une hypertension essentielle résistante à une quadrithérapie, après validation par un centre expert.</div></div><div><div>Renal denervation is a validated, innovative strategy to effectively reduce blood pressure in both treatment-resistant and mildly treated hypertensive patients.</div><div>Its average efficacy is comparable to that of a full-dose antihypertensive drug, although interindividual variability in response remains significant.</div><div>Identifying predictive markers of response is a key challenge to improve patient selection for renal denervation.</div><div>In the absence of such markers, strict adherence to the care pathway outlined in the French consensus ensures appropriate candidate selection.</div></div>","PeriodicalId":100859,"journal":{"name":"La Presse Médicale Formation","volume":"6 4","pages":"Article 100693"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144912862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prise en charge de l’hypertension artérielle de la grossesse 处理妊娠高血压
La Presse Médicale Formation Pub Date : 2025-08-01 DOI: 10.1016/j.lpmfor.2025.100686
Jacques Blacher , Valérie Olié , Bénédicte Sautenet
{"title":"Prise en charge de l’hypertension artérielle de la grossesse","authors":"Jacques Blacher ,&nbsp;Valérie Olié ,&nbsp;Bénédicte Sautenet","doi":"10.1016/j.lpmfor.2025.100686","DOIUrl":"10.1016/j.lpmfor.2025.100686","url":null,"abstract":"<div><div>L’HTA complique plus de 7 % des grossesses en France. Toutes les HTA de la grossesse (PA<!--> <!-->≥<!--> <!-->140/90<!--> <!-->mmHg au cabinet, ≥ 135/85<!--> <!-->mmHg en ambulatoire diurne) doivent être traitées. Seules quatre molécules sont indiquées en première intention dans le traitement de l’HTA pendant la grossesse : l’alpha-méthyldopa, le labétalol, la nicardipine et la nifédipine. L’HTA de la grossesse s’associe à une augmentation des risques cardiovasculaires, métaboliques et rénaux à moyen et long terme après l’accouchement.</div></div><div><div>Hypertension complicates over 7% of pregnancies in France. All cases of hypertension during pregnancy (office BP<!--> <!-->≥<!--> <!-->140/90<!--> <!-->mmHg, daytime ambulatory BP<!--> <!-->≥<!--> <!-->135/85<!--> <!-->mmHg) must be treated. Only four molecules are indicated as first-line treatment for hypertension during pregnancy: alpha-methyldopa, labetalol, nicardipine and nifedipine. Hypertension during pregnancy is associated with increased cardiovascular, metabolic and renal risks in the medium and long term after delivery.</div></div>","PeriodicalId":100859,"journal":{"name":"La Presse Médicale Formation","volume":"6 4","pages":"Article 100686"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144912744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ours redaction 熊日期
La Presse Médicale Formation Pub Date : 2025-08-01 DOI: 10.1016/S2666-4798(25)00103-X
{"title":"Ours redaction","authors":"","doi":"10.1016/S2666-4798(25)00103-X","DOIUrl":"10.1016/S2666-4798(25)00103-X","url":null,"abstract":"","PeriodicalId":100859,"journal":{"name":"La Presse Médicale Formation","volume":"6 4","pages":"Article 100697"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144912679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recommandations ESC 2024 : quoi de nouveau par rapport à celles de l’ESH 2023 ? ESC 2024建议：与ESH 2023有什么不同？
La Presse Médicale Formation Pub Date : 2025-08-01 DOI: 10.1016/j.lpmfor.2025.100692
Emmanuelle Vidal-Petiot , Rosa-Maria Bruno
{"title":"Recommandations ESC 2024 : quoi de nouveau par rapport à celles de l’ESH 2023 ?","authors":"Emmanuelle Vidal-Petiot ,&nbsp;Rosa-Maria Bruno","doi":"10.1016/j.lpmfor.2025.100692","DOIUrl":"10.1016/j.lpmfor.2025.100692","url":null,"abstract":"<div><div>Les recommandations ESH 2024 sur la prise en charge de la pression artérielle (PA) élevée et de l’hypertension insistent tout particulièrement sur les points suivants :</div><div>– l’importance de la mesure de la PA en dehors du cabinet médical,</div><div>– une nouvelle classification de la PA (une PAS entre 120–139 ou une PAD entre 70 et 89 définit une PA élevée),</div><div>– importance d’une stratification précise du risque cardiovasculaire, notamment en cas de PA élevée,</div><div>– screening systématique de l’ hyperaldostéronisme primaire chez tous les patients hypertendus,</div><div>– l’objectif est une PAS entre 120 et 129<!--> <!-->mmHg, à condition que ce niveau tensionnel soit bien toléré,</div><div>– l’initiation du traitement par une bithérapie fixe à faible dose est recommandée,</div><div>– une trithérapie fixe à faible dose est désormais proposée en deuxième intention,</div><div>– indication à la dénervation rénale dans des cas spécifiques, en centre expert.</div></div><div><div>The 2024 ESH recommendations on the management of elevated blood pressure (BP) and hypertension particularly emphasize the following points:</div><div>– the importance of measuring BP outside the physician's office,</div><div>– a new BP classification (SBP between 120–139 or DBP between 70 and 89 defines elevated BP),</div><div>– importance of precise cardiovascular risk stratification, particularly in cases of elevated BP,</div><div>– systematic screening for primary hyperaldosteronism in all hypertensive patients,</div><div>– the target is SBP between 120 and 129<!--> <!-->mmHg, provided this BP level is well tolerated,</div><div>– treatment initiation with a low-dose fixed-dose combination therapy is recommended,</div><div>– a low-dose fixed triple therapy is now proposed as second-line treatment,</div><div>– indication for renal denervation in specific cases, in expert centers.</div></div>","PeriodicalId":100859,"journal":{"name":"La Presse Médicale Formation","volume":"6 4","pages":"Article 100692"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144912857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypertension artérielle secondaire : ce qu’il faut savoir en pratique 继发性高血压的实践知识
La Presse Médicale Formation Pub Date : 2025-08-01 DOI: 10.1016/j.lpmfor.2025.100687
Julien Mallart-Riancho, Laurence Amar
{"title":"Hypertension artérielle secondaire : ce qu’il faut savoir en pratique","authors":"Julien Mallart-Riancho,&nbsp;Laurence Amar","doi":"10.1016/j.lpmfor.2025.100687","DOIUrl":"10.1016/j.lpmfor.2025.100687","url":null,"abstract":"<div><div>L’hypertension artérielle secondaire concerne 6 à 20 % des patients hypertendus. Il faut la rechercher activement devant certains profils (HTA<!--> <!-->&lt;<!--> <!-->40 ans, HTA grade 3, présence d’une hypokaliémie, signes cliniques évocateurs). Les principales causes sont : l’hyperaldostéronisme primaire, la sténose de l’artère rénale, le syndrome de Cushing, ou le phéochromocytome. Le dépistage ciblé est recommandé plutôt qu’un dépistage généralisé, en tenant compte du rapport bénéfice/coût.</div></div><div><div>Secondary hypertension affects 6–20% of hypertensive patients. Clinicians should actively screen in key situations (e.g., HTN before age 40, grade 3 HTN, low potassium, suggestive symptoms). Main causes include primary aldosteronism, renal artery stenosis, Cushing's syndrome, pheochromocytoma, etc. A targeted diagnostic approach is preferred over systematic screening, given the unclear cost-effectiveness.</div></div>","PeriodicalId":100859,"journal":{"name":"La Presse Médicale Formation","volume":"6 4","pages":"Article 100687"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144912673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Les journées d’hypertension artérielle de la Société française d’hypertension artérielle 法国高血压协会的高血压日
La Presse Médicale Formation Pub Date : 2025-08-01 DOI: 10.1016/j.lpmfor.2025.100683
Marilucy Lopez-Sublet , Philippe Sosner , Camille Roubille , Béatrice Duly-Bouhanick
{"title":"Les journées d’hypertension artérielle de la Société française d’hypertension artérielle","authors":"Marilucy Lopez-Sublet ,&nbsp;Philippe Sosner ,&nbsp;Camille Roubille ,&nbsp;Béatrice Duly-Bouhanick","doi":"10.1016/j.lpmfor.2025.100683","DOIUrl":"10.1016/j.lpmfor.2025.100683","url":null,"abstract":"","PeriodicalId":100859,"journal":{"name":"La Presse Médicale Formation","volume":"6 4","pages":"Article 100683"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144912985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sommaire 摘要
La Presse Médicale Formation Pub Date : 2025-08-01 DOI: 10.1016/S2666-4798(25)00105-3
{"title":"Sommaire","authors":"","doi":"10.1016/S2666-4798(25)00105-3","DOIUrl":"10.1016/S2666-4798(25)00105-3","url":null,"abstract":"","PeriodicalId":100859,"journal":{"name":"La Presse Médicale Formation","volume":"6 4","pages":"Article 100699"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144912678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CV1 / Sommaire CV1 /摘要
La Presse Médicale Formation Pub Date : 2025-08-01 DOI: 10.1016/S2666-4798(25)00101-6
{"title":"CV1 / Sommaire","authors":"","doi":"10.1016/S2666-4798(25)00101-6","DOIUrl":"10.1016/S2666-4798(25)00101-6","url":null,"abstract":"","PeriodicalId":100859,"journal":{"name":"La Presse Médicale Formation","volume":"6 4","pages":"Article 100695"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144912677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信